Nike recovery underway, analyst expects company to continue to dominate long-term

Published 01/07/2025, 15:36
© Reuters.

Investing.com -- Nike is on the path to recovery and poised to maintain its leadership in athletic apparel and footwear, according to a new note from Argus. 

The firm upgraded the stock to Buy from Hold in a note to clients on Tuesday, setting a price target of $85.

“We believe a recovery is underway,” said the firm, citing the company’s efforts to clear excess inventory in the second half of fiscal 2025.

“Most of the company’s products are up-to-date and attracting customers,” they added.

Argus highlighted Nike’s improved pricing strategy through its e-commerce channel and noted ongoing supply chain adjustments. 

“Nike plans to reduce its imports from China to the high-single-digits, compared to a mid-teens level previously,” the report stated.

Despite competitive pressures, the long-term view remains bullish. “We expect Nike (NYSE:NKE) to continue to dominate the athletic apparel and footwear markets,” Argus wrote. 

The firm pointed to Nike’s strong positioning in premium footwear, supported by “marketing strength and endorsements from famous athletes.”

According to Argus, Nike’s globally recognized brand, innovative product pipeline, economies of scale, and growing presence in emerging markets all support a positive investment case. “The long-term outlook remains bright,” said the firm.

“Although the industry remains fiercely competitive, we expect the company to build on its dominant position,” concluded Argus.

 

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.